Phar Vision Advisers, LLC Boston Scientific Corp Transaction History
Phar Vision Advisers, LLC
- $178 Billion
- Q3 2025
A detailed history of Phar Vision Advisers, LLC transactions in Boston Scientific Corp stock. As of the latest transaction made, Phar Vision Advisers, LLC holds 5,478 shares of BSX stock, worth $562,535. This represents 0.3% of its overall portfolio holdings.
Number of Shares
5,478
Previous 2,373
130.85%
Holding current value
$562,535
Previous $255 Million
109.83%
% of portfolio
0.3%
Previous 0.37%
Shares
3 transactions
Others Institutions Holding BSX
# of Institutions
1,950Shares Held
1.26BCall Options Held
10.9MPut Options Held
8.94M-
Vanguard Group Inc Valley Forge, PA138MShares$14.2 Billion0.21% of portfolio
-
Black Rock Inc. New York, NY126MShares$13 Billion0.22% of portfolio
-
State Street Corp Boston, MA64.9MShares$6.67 Billion0.23% of portfolio
-
Bank Of America Corp Charlotte, NC33.9MShares$3.48 Billion0.23% of portfolio
-
Primecap Management CO Pasadena, CA33.1MShares$3.4 Billion2.56% of portfolio
About BOSTON SCIENTIFIC CORP
- Ticker BSX
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,431,609,984
- Market Cap $147B
- Description
- Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...